invest

De Leon calls for climate divestment, seeks to pull coal investments from CALPERS, CALSTRS

State and local leaders break ground at a Louisville, Ky., coal-burning power plant in November 2012.; Credit: Dylan Lovan/AP

Molly Peterson

California State Senator Kevin de Leon says he’ll introduce legislation next month to get the state’s public employees retirement system off of coal.

Just back from ho-hum international talks in Lima, where he was a member of California's delegation, de Leon spoke at a conference in Oakland. It was sponsored by NextGen Climate, a nonpartisan group founded by billionaire philanthropist Tom Steyer to raise the profile of climate change among issues in the U.S. political debate.

“With coal power in retreat, and the value of coal dropping, it’s time for us to lead again in moving our massive state portfolios to lower carbon investments,” De Leon said. “Divestment is about matching your values with your investment strategy — and still seeing positive financial returns… California has prohibited its energy companies from buying or importing coal power, and state funds should match that.”

De Leon proposes to divest the nation’s two largest public pension funds from coal. The California Public Employees Retirement System, or CALPERS, is the nation’s largest, controlling about $295 billion as of the end of September.  The California School Teachers Retirement System is a sister fund for pensions of nearly 850,000 California teachers. CALSTRS controls another $187.1 billion dollars in potential investments.

Burning coal for energy is a major source of greenhouse gases that are warming the planet. The move would lend momentum to a divestment movement already underway, largely targeted at investment funds belonging to colleges and universities nationwide.

Stanford and Pitzer College in Claremont are among a dozen universities that have pulled investments out of the coal industry. But others, including the University of California have refused. 

This content is from Southern California Public Radio. View the original story at SCPR.org.




invest

PhonePe gets USD 28 mln investment from Flipkart

Walmart-owned ecommerce player Flipkart has invested USD 28...




invest

Bixin launches USD 66 mln Fund of Funds to assist crypto investments

Hong Kong-based cryptocurrency company Bixin Global has launched a Fund of Funds (FoF) worth USD 66 million.




invest

Councilman calls for investigation of Playa del Rey gas field

A decade-by-decade display of how many active gas storage wells are still in use by Southern California Gas Company. Source: Division of Oil, Gas and Geothermal Resources and SoCalGas; Credit: Aaron Mendelson/KPCC

Sharon McNary

The Aliso Canyon gas leak broke out near Porter Ranch nearly four years ago. On Tuesday a City Councilman called for an investigation of a different underground gas field after troubling images surfaced on video. 

The video uses a special infrared camera to show a duck swimming in the Ballona Wetlands amid bubbles of gas. An environmental advocacy group, Food and Water Watch, says the gas is methane.  They released the video this week to push for the city to investigate the underground gas storage field in nearby Playa del Rey.

Southern California Gas Co. says the gas surfacing in the wetlands is naturally occurring and unrelated to its underground natural gas storage field in Playa del Rey.

 

This content is from Southern California Public Radio. View the original story at SCPR.org.




invest

Budweiser APAC to invest more in ecommerce

APAC-based lager Budweiser has announced...




invest

Why These 2 Investment Professionals Say This Telemedicine Company Is One of Their Top Picks

Source: Streetwise Reports   04/28/2020

As the coronavirus pandemic has accelerated the move to telemedicine, two investment professionals are following CloudMD, a small cap rapidly expanding in Canada.

News Flash: On May 7, CloudMD announced that it is partnering with IDYA4 Corp. for it to resell the health technology firm's Livecare technology in the U.S.. Read more here.

News Flash: On May 4, CloudMD announced that it is partnering with Save-On-Foods grocery stores and Pure Integrative Pharmacy to pilot on demand, integrated virtual patient care through telemedicine kiosks placed in pharmacies' existing consult rooms. Read more here.

As people are avoiding going to doctor's offices and hospitals during the coronavirus pandemic, telemedicine has taken off. Two investment professionals, Bruce Campbell and Keith Schaefer, have called CloudMD Software & Services Inc. (DOC:CSE; DOCRF:OTCQB; 6PH:FSE), a small-cap Canadian telemedicine firm, a top pick.

Bruce Campbell, founder and portfolio manager of Stonecastle Investment Management, spoke about CloudMD on April 27 on BNN:

"The first top pick is CloudMD Software, a technological medical play. We've tried to look at opportunities that are really going to be able to take advantage of Covid and this is one of the ones that we think is; what they do is telemedicine.

"The jumping off point for TeleHealth is here and I think CloudMD is the best pure-play TeleHealth stock right now." - Keith Schaefer

If you look back at a year ago, where everyone had to go to the doctor, and now all of the different provinces have opened up billing codes, so that now we don't have to go into a doctor's office. We can do a virtual doctor's visit and the doctor gets paid just like they do with an in-house appointment. Obviously with everything that has happened with this crisis, people really don't want to go into a doctor's office and they need a prescription renewal or something like that.

If you look at CloudMD's peers in the U.S., there is a company called Teladoc, which is a big U.S. company that does the same thing. Obviously, the size of the market is different, but the multiple it trades at is multiple times higher than where CloudMD is.

CloudMD is just starting to gain adoption. They started off here in BC, they have moved to Ontario, and they are going to be rolling out really across the country, so tons of opportunity for a company like this. They will probably change the way that we view our doctor and our healthcare visits going forward."

Keith Schaefer, editor and publisher of Oil & Gas Investments Bulletin, is also following CloudMD, and wrote:

"An entirely new—and highly profitable—industry is being borne out in 2020—TeleHealth. CloudMD Software & Services Inc. (DOC:CSE; DOCRF:OTCQB; 6PH:FSE) is my favorite way to play TeleHealth. It's growing quickly with over 100,000 patients registered on its app and over 3000 doctors in 8 provinces in its Electronic Medical Records—EMR—system. It has MULTIPLE revenue streams and it just moved into Canada's largest market—Ontario—setting up an even faster growth rate.

The recent spread of coronavirus is only accelerating this. Covid-19 has forever changed how we all will think about visiting a hospital or seeing our doctor. We really don't want to do that at all, if possible. It will have a very positive and long lasting impact on TeleHealth.

TeleHealth companies in Canada are getting paid more money for services than bricks-and-mortar clinics, and have a fraction of the costs. Doctors want more of it, patients want more of it, government wants more of it—and the Market REALLY wants more of it. Everybody wins here; there is no downside.

The rapid scale-up and profitability is key for investors.

CloudMD is established, growing quickly and trading at a fraction of its peers. The average multiple of competitors in the sector trade at 5-7x revenue, and CloudMD is trading way below that at 2.5x per revenue. But realize that the Canadian use of telemedicine is still just a fraction of where it is in the U.S—so the quick, early upside is even bigger.

The market desperately wants to own TeleHealth right now. I see CloudMD as the best way to do that in the junior sector (where the leverage is!).

For this stock to have a major run all that needs to happen is for institutional investors to wake-up to the fact that the company exists. That's happening now with the company entering the province of Ontario—which has 14.5 million people—over one-third of Canada's population.

CloudMD is a fully integrated health care company—kind of like a hospital-in-the-sky. They do have five bricks-and-mortar clinics, but they also own their own EMR—Electronic Medical Records—system that operates in eight provinces and is used by over 3,000 doctors and is supported by an in-house 25 person development team. They have their own CloudMD app—which has over 100,000 registered patients already.

The EMR gives CloudMD a recurring monthly revenue stream, which The Street loves. The app gives them high-margin fees from doctors, specialists and groups like massage therapists & counselors. These people are revenue, not costs. As I said, full hospital-in-the-sky. Multiple revenue sources with lower costs.

To schedule a virtual doctor's appointment all that a patient has to do is download the free CloudMD app and then arrange an appointment with one of the doctors. There is zero charge for the patient and they can see a doctor very quickly.

CloudMD can scale up the number of patients VERY quickly—and they are. Every aspect of healthcare that's very fractured and disjointed will now be in the one CloudMD ecosystem.
Everyone wins with this system. Patients, doctors, the medical system, society, even investors. Everyone.

Doctors who have signed up with CloudMD work remotely from home or wherever they are (like their winter home down south). The rapid scale-up potential excites me. CloudMD can add in unlimited number of doctors and patients—so it has a virtually unlimited ability to scale quickly with little incremental cost.

Profit margins are wide and there is no cap on the number of customers that can be handled.

After a patient has an appointment, CloudMD bills the government directly just like every bricks-and-mortar clinic in Canada does. CloudMD records 100% of the revenue and gets to keep 30% of the billing for every patient that is seen through telemedicine, which is actually 10% more than what a bricks-and-mortar clinic receives. That is because the governments are trying to push TeleHealth. The doctor gets the other 70% and doesn't have to deal with any headaches of commuting or running a business.

Without the overhead of a bricks-and-mortar clinic, AND more revenue, CloudMD will be much more profitable than traditional healthcare stocks. Faster scale, more cash flow. And they just entered Canada's largest market. This is the right stock in the right market at the right time. That's the great thing about this business model. It's very scalable, very easy, and it grows very quickly.

CloudMD has been growing its recurring SAAS (Software-as-a-Service) revenue by 30% YoY with its EMR system. But this year the company is expecting that doctor growth to be much much higher—with a new full time sales team and the coronavirus pandemic. SaaS revenue is highly lucrative!

The jumping off point for TeleHealth is here and I think CloudMD is the best pure-play TeleHealth stock right now."

Read Keith Schaefer's entire article here.

Watch Bruce Campbell of StoneCastle Investments share his top picks: CloudMD, Lightspeed and Viemed.

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Disclosure:
1) Keith Schaefer: I, or members of my immediate household or family, own shares of the following companies mentioned in this article: CloudMD. I personally am, or members of my immediate household or family are, paid by the following companies mentioned in this article: CloudMD. My company has a financial relationship with the following companies mentioned in this article: None. Additional disclosures are listed below.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees. As of the date of this article, an affiliate of Streetwise Reports has a consulting relationship with CloudMD. Please click here for more information. An affiliate of Streetwise Reports is conducting a digital media marketing campaign for this article on behalf of CloudMD. Please click here for more information.
3) Statements and opinions expressed are the opinions of the author and not of Streetwise Reports or its officers. The author is wholly responsible for the validity of the statements. The author was not paid by Streetwise Reports for this article. Streetwise Reports was not paid by the author to publish or syndicate this article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
4) This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of CloudMD, a company mentioned in this article.

Additional Disclosures

Keith Schaefer Disclosures:
CloudMD has reviewed and sponsored this article. The information in this newsletter does not constitute an offer to sell or a solicitation of an offer to buy any securities of a corporation or entity, including U.S. Traded Securities or U.S. Quoted Securities, in the United States or to U.S. Persons. Securities may not be offered or sold in the United States except in compliance with the registration requirements of the Securities Act and applicable U.S. state securities laws or pursuant to an exemption therefrom. Any public offering of securities in the United States may only be made by means of a prospectus containing detailed information about the corporation or entity and its management as well as financial statements. No securities regulatory authority in the United States has either approved or disapproved of the contents of any newsletter.

Keith Schaefer is not registered with the United States Securities and Exchange Commission (the "SEC"): as a "broker-dealer" under the Exchange Act, as an "investment adviser" under the Investment Advisers Act of 1940, or in any other capacity. He is also not registered with any state securities commission or authority as a broker-dealer or investment advisor or in any other capacity.

Bruce Campbell, Stonecastle Investment Management:
A guest firm/affiliate holds a position in CloudMD. There is no guest position held, members of his household do not hold positions and CloudMD is not an investment banking client.

( Companies Mentioned: DOC:CSE; DOCRF:OTCQB; 6PH:FSE, )




invest

Alexion's Buyout of Portola Pharmaceuticals Gets Investors' Blood Flowing

Source: Streetwise Reports   05/05/2020

Shares of Portola Pharmaceuticals traded 130% higher after the company reported that it has received an $18 per share buyout offer from Alexion Pharmaceuticals.

Commercial-stage biotechnology company Portola Pharmaceuticals Inc. (PTLA:NASDAQ), which focuses on blood-related disorders, and global biopharmaceuticals firm Alexion Pharmaceuticals Inc. (ALXN:NASDAQ) announced that they have entered into a definitive merger agreement for Portola to be acquired by Alexion.

The acquisition is said to provide a key addition to Alexion's diversified commercial portfolio. The report indicated that the merger agreement has already been unanimously approved each of the company's boards of directors.

The report explained that "Portola's commercialized medicine, Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], marketed as Ondexxya® in Europe, is the first and only approved Factor Xa inhibitor reversal agent, and has demonstrated transformative clinical value by rapidly reversing the anticoagulant effects of Factor Xa inhibitors rivaroxaban and apixaban in severe and uncontrolled bleeding."

Portola's President and CEO Scott Garland commented, "In developing and launching Andexxa, Portola has established a strong foundation for changing the standard of care for patients receiving Factor Xa inhibitors that experience a major, life-threatening bleed. Andexxa rapidly reverses the pharmacologic effect of rivaroxaban and apixaban within two minutes, reducing anti-Factor Xa activity by 92 percent...Given their enhanced resources, global footprint and proven commercial expertise, we look forward to working with Alexion to maximize the value of Andexxa. With their commitment to commercial excellence, together, we will be able to drive stronger utilization of Andexxa, increase penetration and accelerate adoption in the critical care setting."

Ludwig Hantson, Ph.D., CEO of Alexion, remarked, "The acquisition of Portola represents an important next step in our strategy to diversify beyond C5. Andexxa is a strategic fit with our existing portfolio of transformative medicines and is well-aligned with our demonstrated expertise in hematology, neurology and critical care...We believe Andexxa has the potential to become the global standard of care for patients who experience life-threatening bleeds while taking Factor Xa inhibitors apixaban and rivaroxaban. By leveraging Alexion's strong operational and sales infrastructure and deep relationships in hospital channels, we are well positioned to expand the number of patients helped by Andexxa, while also driving value for shareholders."

The firms advised that "under the terms of the merger agreement, a subsidiary of Alexion will commence a tender offer to acquire all of the outstanding shares of Portola's common stock at a price of $18 per share in cash." Alexion plans to fund the purchase with existing cash on hand and the transaction is expected to close in Q3/20. The purchase is subject to approval by a majority interest of Portola's common stockholders tendering their shares along with ordinary closing conditions and regulatory approvals. The company noted that "following successful completion of the tender offer, Alexion will acquire all remaining shares not tendered in the offer at the same price of $18 per share through a merger."

Alexion is a global biopharmaceutical company based in Boston, Mass., with offices in 50 countries worldwide. The company states that it has been "the global leader in complement biology and inhibition for more than 20 years and that it has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome, as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor antibody-positive generalized myasthenia gravis and neuromyelitis optica spectrum disorder."

Portola is headquartered in South San Francisco, Calif., and is a commercial-stage biopharmaceutical company focused on treating patients with serious blood-related disorders. Specifically, the company is engaged in developing and commercializing novel therapeutics in order to advance the fields of thrombosis and other hematologic conditions. The firm listed that its first two commercialized products are Andexxa® and Bevyxxa® (betrixaban), and that it is also advancing and developing cerdulatinib, a SYK/JAK inhibitor for use in treatment of hematologic cancers.

Portola Pharmaceuticals started off the day with a market capitalization of around $609.0 million with approximately 78.5 million shares outstanding and a short interest of about 23.0%. PTLA shares opened 130% higher today at $17.85 (+$10.09, +130.03%) over yesterday's $7.85 closing price. The stock has traded today between $17.71 and $17.91 per share and is currently trading at $17.83 (+$10.07, +129.77%).

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Disclosure:
1) Stephen Hytha compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. He or members of his household own securities of the following companies mentioned in the article: None. He or members of his household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases.
6) This article does not constitute medical advice. Officers, employees and contributors to Streetwise Reports are not licensed medical professionals. Readers should always contact their healthcare professionals for medical advice.




invest

Large-scale early flood warning systems provide high returns on investment

Continental-scale early flood warning systems in Europe can provide significant monetary benefits by reducing flood damage and associated costs. Specifically, a new study found that the return from the European Flood Awareness System (EFAS) and available flood damage data has the potential to be as high as approximately 400 euros for every one euro invested.




invest

Cloud technologies got the maximum investment from Indian firms in last 2 years: EY survey

Sixty-four per cent of organizations in India and Europe invested in cloud technologies in the last two years, followed by IoT, where 51% firms made investments.




invest

Vista Equity Partners to invest Rs 11,367 crore in Jio Platforms for 2.32% stake

With the latest deal, Jio Platforms is set to net a combined Rs 60,596 crore for the unit of Reliance Industries which comprises mainly its telecom business under Reliance Jio Infocomm




invest

Researchers investigate suitability of rocks at Ketzin for storing CO2

In 2008, the injection of CO2 started at Ketzin in Germany, Europe’s first onshore carbon storage site. A recently published paper has reported on the findings of experiments conducted on the rocks at Ketzin, which contributed important information about their safety and feasibility for storing CO2. No significant changes to the rocks were observed 15 months after they had been injected with CO2.




invest

Viewing fish stocks as economic investments

In economic terms, overfishing can be regarded as borrowing natural capital at a high rate of interest, according to a new study. Combining economic and biological principles, the study develops a concept that expresses overfishing in terms of the ‘interest’ that the fishing industry have to repay in future years as a result of lost income from depleted fish stocks.




invest

Coded Emails? BitCrypt? Computer Forensic Investigation




invest

What makes railway noise annoying? Research investigates

A new study into the impact of railway noise has revealed that it is not just the level of noise that contributes to annoyance for local residents, but also the number of trains and the vibrations they cause. As railway transport is likely to increase in coming years, plans are needed to reduce these effects.




invest

Cycling infrastructure: financial returns can be over 20 times the initial investment

Transport policies that produce physically segregated cycle lanes on main roads, combined with low-speed local streets, will boost numbers of cyclists and provide the best financial return on investment, new research suggests. Using Auckland, New Zealand as a case study the researchers showed that the economic benefits of this policy can outweigh the costs by more than 20 times.




invest

Can legislation encourage environmental investment by businesses?

The exact impact of environmental law on investment by EU industry is relatively unknown. A new study has explored the effects of regulation on four types of industry investment and the results indicate that, in general, regulation tends to encourage more investment, but if restrictions are too tight investment levels can start to fall.




invest

Relationships between energy consumption and economic growth investigated

Renewable energy plays an important role in economic development, according to a recent study which investigated the relationship between economic growth and energy consumption in Europe.




invest

Satellite images as evidence in court: legal obstacles to their use in environmental investigations

Satellite images could be used as evidence in environmental crime cases in the future, a Belgian judge and researcher predicts. However, there are several obstacles to their use at present. Notably, they do not provide sufficiently detailed evidence for the courtroom.




invest

Environmental impact investment

Impact investing refers to investments that intend to generate measurable social and/or environmental impacts, as well as a financial return. Often described as ‘doing good while doing well’ it is part of a wider strategy to shift finance towards more sustainable projects. This Future Brief explores research into impact investment, with an emphasis on environmental impact investing in Europe.




invest

Persistent Systems invests in big data firm Cazena

The company has gained significant traction as enterprises face massive skills shortages in big data, cloud and associated development operations, or ‘DevOps’.




invest

Data-crunching investments by insurers rise 20% in 2019

The driving force is the challenges that are emerging due to substandard and unstructured data




invest

Reliance Retail's fashion business invests in data intelligence to go hyperlocal this year

Reliance Retail has deployed a technology team to develop applications in order to create seamless online and offline experience in the coming financial year.




invest

66% manufacturing firms pick big data as top investment priority: Study

Sixty-six per cent of manufacturing companies voted for big data, predictive analytics as their top investment priority in the next two years, followed by the Industrial Internet of Things (IIoT) and sensors, cloud/integrated platforms and robotic process automation, a new study revealed on Friday.




invest

New FDI policy trigger concerns over investments from Taiwan

Some MNC banks may seek clarity from RBI; companies in a fix over Chinese inflow in the rights issue.




invest

For cloud giants, usage soars but tech investment delays hobble revenue growth

The cloud giants have seen a drop-off in new contracts from big clients for server storage and to overhaul tech.




invest

Microsoft to invest $1.5 billion in Italian cloud business

Microsoft Corp. said on Friday it would create its first datacentre region in Italy under a $1.5 billion investment plan as the U.S. company expands its cloud computing services to more locations across the world.




invest

Vista Equity Partners to invest Rs 11,367 crore in Jio Platforms for 2.32% stake

With the latest deal, Jio Platforms is set to net a combined Rs 60,596 crore for the unit of Reliance Industries which comprises mainly its telecom business under Reliance Jio Infocomm




invest

Microsoft to invest $1.5 billion in Italian cloud business

Microsoft Corp. said on Friday it would create its first datacentre region in Italy under a $1.5 billion investment plan as the U.S. company expands its cloud computing services to more locations across the world.




invest

Google invests $670 million to expand its data centre in Finland

The new construction will add to Google’s existing data-centre complex in Hamina on the south coast of Finland.




invest

Amazon invests Rs 2,500 crore in marketplace and data centre units

The investment follows a Rs1,715 crore infusion into Amazon’s payments and wholesale arms last month.




invest

How to attract PES investment from businesses?

A new study has looked at why and how much private sector companies are prepared to invest in Payment for Ecosystem Services (PES) schemes for tropical forests. Understanding companies' motivations and expectations can help develop new sources of funding for PES schemes from the private sector, increasing the area of tropical forest conserved worldwide.




invest

An investigation into the receptivity of English farmers to collaborative agri-environment schemes

A team of UK researchers has analysed interviews with a selection of farmers from across England in an effort to determine the sociocultural factors influencing their decisions to cooperate with each other on collaborative agri-environment schemes (cAES). Results from this study have significance for the success of AES in the region, as it may be that only by collaborating on such schemes can farmers adequately conserve crucial landscape-scale ecological processes. The study finds that cAES which provide greater flexibility, with opportunities for farmer involvement in scheme design and locally targeted and clearly defined aims, are more likely to gain support from farmers. Farmers might also be more receptive to environmental interventions if they could be partially involved in cAES.




invest

Study investigates attitudes of soil-remediation experts to phytoremediation

An investigation into the attitudes of Canadian soil-remediation experts has shown that they tend to prefer conventional remediation methods over phytoremediation — which relies on plants to clean soils — despite evidence that the latter can have advantages. The researchers behind the study highlight that this ‘status-quo bias’ poses a barrier to the uptake of novel technologies such as phytoremediation, and that scientists may need to find different ways of disseminating evidence to increase the use of new techniques among practitioners.




invest

What encourages farmers to participate in collective biogas investment?

Biogas production from waste and manure has the potential to make a contribution to environmental, energy and climate policy objectives. However, farmer engagement has remained persistently low. A new study, involving 461 Danish farmers, has investigated their willingness to participate in collective biogas investment (where two or more farmers collectively own a biogas plant). The study suggests that the majority of farmers are willing to participate in partnership-based biogas investment (PBI) and identifies the main factors driving willingness to participate and the intensity of participation. These findings are relevant to policymaking aimed at increasing biogas production and stakeholder engagement.




invest

WA court orders $175k forfeiture after AFP investigation

The Supreme Court of Western Australia has ordered $175,100 be forfeited to the Commonwealth, following an Australian Federal Police (AFP) investigation into proceeds of crime seized at Perth Airport in 2018.










invest

​Medical, tech investments pay off in Covid-19 war

Singapore's expertise in fighting the coronavirus is the fruit of the continuing investment in the health and biomedical sciences that the country started decades ago. One scientist featured in the article is microbiologist Julien Lescar from NTU’s School of Biological Sciences....




invest

Organic dairy co-op MOOMilk lands $3 million in investment

The small Maine-based co-op, which has struggled to gain a hold in the marketplace, received $3 million in much-need investment.



  • Sustainable Business Practices

invest

State Dept. faces Keystone XL investigation

Amid accusations of bias and corruption, the agency's inspector general will investigate its review of the proposed oil-sands pipeline from Canada.




invest

The Sustainable Forestry Initiative invests in community and conservation

Forest certification program announces its new Conservation and Community Partnerships Grant program.



  • Wilderness & Resources

invest

IKEA announces first U.S. investment in wind energy

IKEA gusts into the U.S. wind energy sector with an investment in an Illinois farm capable of generating enough annual energy to power 70 stores.




invest

How to fight climate change: Invest in inner cities

A new online investing platform will fund energy-efficiency improvements for churches and nonprofits in poor neighborhoods.




invest

Transocean the subject of tax loophole investigation

A '60 Minutes' investigation shows that the company that owned the Deepwater Horizon rig moved its headquarters to avoid paying taxes.




invest

Green investing: Put your money where your Earth is

Environmentally and socially responsible investment companies help make ecosystems and the economy more sustainable.




invest

Green investing 101

Bloomberg On Demand's Green Investing video is a great primer for individuals who want to add more eco-friendly investments to their portfolio.